{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:13:11Z","timestamp":1780704791486,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.path.2020.09.010","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T23:31:59Z","timestamp":1610235119000},"page":"111-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Salivary Duct Carcinoma"],"prefix":"10.1016","volume":"14","author":[{"given":"Mobeen","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2020.09.010_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00301495","article-title":"Speichelgangcarcinome","volume":"192","author":"Kleinsasser","year":"1968","journal-title":"Arch Klin Exp Ohren Nasen Kehlkopfheilkd"},{"issue":"10","key":"10.1016\/j.path.2020.09.010_bib2","doi-asserted-by":"crossref","first-page":"152549","DOI":"10.1016\/j.prp.2019.152549","article-title":"Salivary duct carcinoma: a case report of oncocytic variant with possible treatment implications and review of literature","volume":"215","author":"Sekhri","year":"2019","journal-title":"Pathol Res Pract"},{"issue":"12","key":"10.1016\/j.path.2020.09.010_bib3","doi-asserted-by":"crossref","first-page":"E100","DOI":"10.1002\/hed.25392","article-title":"Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas","volume":"40","author":"Park","year":"2018","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.path.2020.09.010_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archotol.127.9.1075","article-title":"Expression of Androgen receptor, epidermal growth factor receptor, and transforming growth factor $\u03b1$ in salivary duct carcinoma","volume":"127","author":"Fan","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.path.2020.09.010_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200004000-00014","article-title":"Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature","volume":"24","author":"Fan","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.09.010_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12105-017-0798-x","article-title":"Salivary duct carcinoma: an update on morphologic mimics and diagnostic use of androgen receptor immunohistochemistry","volume":"11","author":"Udager","year":"2017","journal-title":"Head Neck Pathol"},{"issue":"2","key":"10.1016\/j.path.2020.09.010_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N","article-title":"Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases","volume":"77","author":"Lewis","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.path.2020.09.010_bib8","series-title":"WHO classification of head and neck tumours","author":"El-Naggar","year":"2017"},{"issue":"11","key":"10.1016\/j.path.2020.09.010_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.5858\/133.11.1763","article-title":"Update on selected salivary gland neoplasms","volume":"133","author":"McHugh","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"S1","key":"10.1016\/j.path.2020.09.010_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12105-013-0456-x","article-title":"Salivary duct carcinoma: new developments\u2014morphological variants including pure in situ high grade lesions; proposed molecular classification","volume":"7","author":"Simpson","year":"2013","journal-title":"Head Neck Pathol"},{"issue":"5","key":"10.1016\/j.path.2020.09.010_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","article-title":"Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression","volume":"39","author":"Williams","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.09.010_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000478-200403000-00004","article-title":"Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance","volume":"28","author":"Nagao","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.path.2020.09.010_bib13","first-page":"E1838","article-title":"Salivary duct carcinoma: clinicopathologic features, morphologic spectrum, and somatic mutations","volume":"38","author":"Luk","year":"2016","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.path.2020.09.010_bib14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00000478-200308000-00004","article-title":"Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases","volume":"27","author":"Simpson","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.09.010_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2559.2005.02136.x","article-title":"Intraoral mucin-rich salivary duct carcinoma","volume":"47","author":"Henley","year":"2005","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2020.09.010_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9020017","article-title":"Androgen receptor signaling in salivary gland cancer","volume":"9","author":"Dalin","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.path.2020.09.010_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1309\/5J4008QRY1HWW5W4","article-title":"Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature","volume":"122","author":"Nagao","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2020.09.010_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2559.2012.04252.x","article-title":"Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes","volume":"61","author":"Di Palma","year":"2012","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.path.2020.09.010_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jamaoto.2015.3930","article-title":"A\u00a020-year review of 75 cases of salivary duct carcinoma","volume":"142","author":"Gilbert","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.path.2020.09.010_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/his.12454","article-title":"Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma","volume":"65","author":"Griffith","year":"2014","journal-title":"Histopathology"},{"issue":"20","key":"10.1016\/j.path.2020.09.010_bib21","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cncr.30179","article-title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations","volume":"122","author":"Chiosea","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.path.2020.09.010_bib22","series-title":"Pathology and genetics of head and neck tumours","author":"Barnes","year":"2005"},{"issue":"7","key":"10.1016\/j.path.2020.09.010_bib23","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00405-019-05454-0","article-title":"Parotid salivary duct carcinoma: a single institution\u2019s 20-year experience","volume":"276","author":"Stodulski","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.path.2020.09.010_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12105-018-0984-5","article-title":"Expression of PTEN, androgen receptor, HER2\/neu, Cytokeratin 5\/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in salivary duct carcinoma","volume":"13","author":"Liang","year":"2019","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.path.2020.09.010_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2019.08.001","article-title":"Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma","author":"Soares","year":"2019","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.09.010_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5858\/arpa.2016-0259-SA","article-title":"New developments in salivary gland pathology: clinically useful ancillary testing and new potentially targetable molecular alterations","volume":"141","author":"Griffith","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.path.2020.09.010_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/arpa.2014-0167-RA","article-title":"Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors","volume":"139","author":"Zhu","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2020.09.010_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s12105-020-01128-0","article-title":"Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor","author":"Bishop","year":"2020","journal-title":"Head Neck Pathol"},{"issue":"1","key":"10.1016\/j.path.2020.09.010_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2020.09.010_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000335222","article-title":"Parotid Gland Metastasis of Breast Cancer: Case Report and Review of the Literature","volume":"6","author":"Ando","year":"2011","journal-title":"Breast Care (Basel)"},{"issue":"11","key":"10.1016\/j.path.2020.09.010_bib31","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","article-title":"Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients","volume":"31","author":"Williams","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2020.09.010_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.humpath.2018.09.009","article-title":"Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy-na\u00efve salivary duct carcinomas","volume":"84","author":"Yang","year":"2019","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2020.09.010_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hed.25035","article-title":"Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in The Netherlands","volume":"40","author":"Boon","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.path.2020.09.010_bib34","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1002\/hed.23383","article-title":"Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy","volume":"36","author":"Soper","year":"2014","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.path.2020.09.010_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hed.23940","article-title":"Clinical activity of androgen deprivation therapy in patients with metastatic\/relapsed androgen receptor-positive salivary gland cancers","volume":"38","author":"Locati","year":"2016","journal-title":"Head Neck"},{"issue":"16","key":"10.1016\/j.path.2020.09.010_bib36","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1200\/JCO.2010.32.8351","article-title":"Androgen receptor\u2013positive salivary duct carcinoma: a disease entity with promising new treatment options","volume":"29","author":"Jaspers","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.path.2020.09.010_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/14656566.9.2.211","article-title":"Androgen deprivation therapy for prostate cancer","volume":"9","author":"Singer","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.path.2020.09.010_bib38","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.path.2020.09.010_bib39","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-09-0238","article-title":"Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance","volume":"16","author":"Williams","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.path.2020.09.010_bib40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1078-0432.CCR-12-1842","article-title":"Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment","volume":"19","author":"Nardi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2020.09.010_bib41","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2019.1875","article-title":"Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)-positive advanced salivary duct carcinoma: a case report","author":"Gibo","year":"2019","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.path.2020.09.010_bib42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1634\/theoncologist.2012-0369","article-title":"Trastuzumab for the treatment of salivary duct carcinoma","volume":"18","author":"Limaye","year":"2013","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.path.2020.09.010_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.18.00545","article-title":"Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma","volume":"37","author":"Takahashi","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2020.09.010_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anndiagpath.2019.04.001","article-title":"PD-L1 expression by immunohistochemistry in salivary duct carcinoma","volume":"40","author":"Hamza","year":"2019","journal-title":"Ann Diagn Pathol"},{"issue":"7","key":"10.1016\/j.path.2020.09.010_bib45","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/jop.12722","article-title":"The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma","volume":"47","author":"Sato","year":"2018","journal-title":"J\u00a0Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.path.2020.09.010_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jso.24266","article-title":"Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas","volume":"114","author":"Mukaigawa","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.path.2020.09.010_bib47","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/PAS.0b013e3182880d5a","article-title":"PIK3CA mutations and PTEN loss in salivary duct carcinomas","volume":"37","author":"Griffith","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"18","key":"10.1016\/j.path.2020.09.010_bib48","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","article-title":"Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer","volume":"22","author":"Dalin","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2020.09.010_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2019.03.004","article-title":"The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement","volume":"88","author":"Dogan","year":"2019","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.path.2020.09.010_bib50","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/annonc\/mdx399","article-title":"Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies","volume":"28","author":"Ross","year":"2017","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.path.2020.09.010_bib51","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.6004\/jnccn.2018.7056","article-title":"First-line treatment of widely metastatic BRAF -mutated salivary duct carcinoma with combined BRAF and MEK inhibition","volume":"16","author":"Lin","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.path.2020.09.010_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.oraloncology.2017.09.008","article-title":"Salivary duct carcinoma: an aggressive salivary gland malignancy with opportunities for targeted therapy","volume":"74","author":"Schmitt","year":"2017","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.path.2020.09.010_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10147-014-0674-6","article-title":"Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma","volume":"20","author":"Masubuchi","year":"2015","journal-title":"Int J Clin Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918120300726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:41:39Z","timestamp":1761748899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918120300726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1875918120300726"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2020.09.010","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary Duct Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2020.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}